These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22933821)

  • 1. Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats.
    Bartlett RM; Beattie BJ; Naryanan M; Georgi JC; Chen Q; Carlin SD; Roble G; Zanzonico PB; Gonen M; O'Donoghue J; Fischer A; Humm JL
    J Nucl Med; 2012 Oct; 53(10):1608-15. PubMed ID: 22933821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A robotic system for 18F-FMISO PET-guided intratumoral pO2 measurements.
    Chang J; Wen B; Kazanzides P; Zanzonico P; Finn RD; Fichtinger G; Ling CC
    Med Phys; 2009 Nov; 36(11):5301-9. PubMed ID: 19994538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
    O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [
    Kelada OJ; Rockwell S; Zheng MQ; Huang Y; Liu Y; Booth CJ; Decker RH; Oelfke U; Carson RE; Carlson DJ
    Mol Imaging Biol; 2017 Dec; 19(6):893-902. PubMed ID: 28409339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Analysis of Dynamic
    Schwartz J; Grkovski M; Rimner A; Schöder H; Zanzonico PB; Carlin SD; Staton KD; Humm JL; Nehmeh SA
    J Nucl Med; 2017 Jun; 58(6):911-919. PubMed ID: 28232611
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Grkovski M; Emmas SA; Carlin SD
    J Nucl Med; 2017 Oct; 58(10):1567-1573. PubMed ID: 28360207
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    McGowan DR; Macpherson RE; Hackett SL; Liu D; Gleeson FV; McKenna WG; Higgins GS; Fenwick JD
    Med Phys; 2017 Sep; 44(9):4665-4676. PubMed ID: 28644546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.
    Wang W; Lee NY; Georgi JC; Narayanan M; Guillem J; Schöder H; Humm JL
    J Nucl Med; 2010 Jan; 51(1):37-45. PubMed ID: 20008982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.
    Grkovski M; Schwartz J; Gönen M; Schöder H; Lee NY; Carlin SD; Zanzonico PB; Humm JL; Nehmeh SA
    J Nucl Med; 2016 Mar; 57(3):334-41. PubMed ID: 26609178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
    Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
    J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
    Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
    J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parametric mapping of [18F]fluoromisonidazole positron emission tomography using basis functions.
    Hong YT; Beech JS; Smith R; Baron JC; Fryer TD
    J Cereb Blood Flow Metab; 2011 Feb; 31(2):648-57. PubMed ID: 20736963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer.
    Cui YL; Wang X; Li XF
    Future Oncol; 2015; 11(20):2841-9. PubMed ID: 26361064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.
    Gagel B; Reinartz P; Dimartino E; Zimny M; Pinkawa M; Maneschi P; Stanzel S; Hamacher K; Coenen HH; Westhofen M; Büll U; Eble MJ
    Strahlenther Onkol; 2004 Oct; 180(10):616-22. PubMed ID: 15480509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.
    Wang W; Georgi JC; Nehmeh SA; Narayanan M; Paulus T; Bal M; O'Donoghue J; Zanzonico PB; Schmidtlein CR; Lee NY; Humm JL
    Phys Med Biol; 2009 May; 54(10):3083-99. PubMed ID: 19420418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors.
    Zanzonico P; Campa J; Polycarpe-Holman D; Forster G; Finn R; Larson S; Humm J; Ling C
    Nucl Med Biol; 2006 Jan; 33(1):65-70. PubMed ID: 16459260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort.
    Riedl CC; Brader P; Zanzonico P; Reid V; Woo Y; Wen B; Ling CC; Hricak H; Fong Y; Humm JL
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):39-46. PubMed ID: 17786438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.
    Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH
    J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?
    Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Kaiser HJ; Stanzel S; Asadpour B; Demirel C; Hamacher K; Coenen HH; Scholbach T; Maneschi P; DiMartino E; Eble MJ
    BMC Cancer; 2007 Jun; 7():113. PubMed ID: 17598907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Analysis of [
    Shi K; Bayer C; Astner ST; Gaertner FC; Vaupel P; Schwaiger M; Huang SC; Ziegler SI
    Mol Imaging Biol; 2017 Feb; 19(1):120-129. PubMed ID: 27379986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.